Monitoring Kidney Injury in Patients Using Lithium
Essential Laboratory Exams
- The American College of Radiology recommends monitoring serum creatinine every 2-3 days if creatinine remains elevated for >2-3 days to assess progression 1.
- The National Kidney Foundation suggests calculating the estimated glomerular filtration rate (eGFR) using formulas like CKD-EPI or MDRD to stage chronic kidney disease, with values <60 mL/min/1.73 m² for >3 months defining chronic kidney disease 2, 3.
- The American College of Radiology recommends evaluating urea (BUN) in conjunction with creatinine to differentiate pre-renal from renal causes 2.
Specific Lithium Evaluation
- The Journal of Clinical Oncology states that serum lithium levels are essential to exclude toxicity, which can occur at doses close to therapeutic levels, with toxicity being closely related to serum concentrations 4, 1.
- The American College of Radiology suggests checking serum electrolytes, including sodium, potassium, and magnesium, as electrolyte disturbances are common in lithium-induced kidney injury 2.
Urinary Evaluation
- The Journal of the American College of Radiology recommends a complete urinalysis with urine density, as reduced urine density indicates nephrogenic diabetes insipidus, a common complication of lithium 2, 1.
- The Kidney International journal suggests that the protein-to-creatinine ratio in a spot urine sample is a practical and cost-effective test to detect proteinuria, even when eGFR is >90 mL/min/1.73 m², and is useful for early monitoring 5.
Additional Exams as Clinically Indicated
- The American College of Radiology recommends considering renal and bladder ultrasonography to exclude post-renal causes (obstruction) if creatinine remains elevated without a clear cause 2, 1.
- The Journal for ImmunoTherapy of Cancer suggests reserving renal biopsy for cases refractory to conservative treatment or when the diagnosis remains uncertain, with acute interstitial nephritis being the most common histopathological finding in lithium renal toxicity 1, 4.
Common Pitfalls and How to Avoid Them
- The Kidney International journal warns that estimated GFR is not reliable when creatinine is changing rapidly, and serum creatinine is more useful than estimated GFR in these cases 5.
- The Journal of Clinical Oncology recommends considering confounding factors such as dehydration, concomitant use of NSAIDs, recent iodinated contrast, and other nephrotoxic medications that can elevate creatinine 4.
Risk Factors for Progression
- The Journal of the American College of Radiology states that older patients with cardiovascular disease have a higher risk of progressing to severe chronic kidney disease (stages 4-5) 2.
- The Kidney International journal suggests that significant kidney damage usually occurs after ≥8 years of lithium use, and creatinine ≥1.3 mg/dL predicts progression to renal failure (≥1.5 mg/dL) 5.
Monitoring Algorithm
| Step | Evaluation |
|---|---|
| 1 | Initial evaluation: creatinine, eGFR, electrolytes, lithium level, urinalysis with density, protein-to-creatinine ratio |
| 2 | If elevated creatinine persists >2-3 days: monitor every 2-3 days (grade 2) or weekly (grade 1) [1] |
| 3 | If creatinine ≥1.3 mg/dL: intensify monitoring, as it predicts progression |
| 4 | If eGFR <60 mL/min/1.73 m²: consider temporary suspension of lithium during severe intercurrent illnesses |
| 5 | If refractory or diagnosis uncertain: consider renal biopsy and referral to nephrology [1] |
Renal Damage with Lithium Use: Incidence and Monitoring
Risk Factors for Renal Damage
- Dehydration, especially during illness, can precipitate lithium toxicity and renal damage, and concomitant use of NSAIDs can increase lithium levels and risk of toxicity, according to Praxis Medical Insights 6
- Concomitant use of NSAIDs can increase lithium levels and risk of toxicity, as reported by Praxis Medical Insights 6
Monitoring Recommendations
- The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommend regular monitoring of renal function, including GFR, electrolytes, and drug levels, for all patients taking potentially nephrotoxic agents such as lithium 7
- Temporary discontinuation of lithium should be considered in people with GFR <60 ml/min/1.73 m² who have serious intercurrent illness that increases risk of acute kidney injury, as suggested by the KDIGO guidelines 7
- During initial treatment, lithium levels should be measured twice per week until stabilized, according to Praxis Medical Insights 6